Literature DB >> 27150621

Erratum to: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.

Alison K McLean1, Cameron Stewart2, Ian Kerridge3,4,5.   

Abstract

Year:  2016        PMID: 27150621      PMCID: PMC4858899          DOI: 10.1186/s13287-016-0329-9

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


× No keyword cloud information.

Erratum

Due to an error during the production process, this article was unintentionally published twice in this journal [1,2] with the following citations and DOIs: McLean AK, Stewart C and Kerridge I: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.Stem Cell Res Ther 2015, 6:12, DOI: 10.1186/scrt543 McLean AK, Stewart C and Kerridge I: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.Stem Cell Res Ther 2015, 6:33, DOI: 10.1186/s13287-015-0047-8 The version McLean AK, Stewart C and Kerridge I: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.Stem Cell Res Ther 2015, 6:12, DOI: 10.1186/scrt543 is to be ignored, and the original article should be cited as: McLean AK, Stewart C and Kerridge I: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.Stem Cell Res Ther 2015, 6:33, DOI: 10.1186/s13287-015-0047-8 The Publisher is issuing this Erratum to alert readers to this error and to confirm the correct citation details and DOI for this article. We apologize for any inconvenience caused.
  1 in total

1.  Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia.

Authors:  Alison K McLean; Cameron Stewart; Ian Kerridge
Journal:  Stem Cell Res Ther       Date:  2015-02-09       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.